Boston Partners’s Phibro Animal Health PAHC Stock Holding History

Boston Partners’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.9M	Buy	+304,347	New	+$10.7M	0.01%	456

Other funds holding PAHC

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Dana Investment Advisors Waukesha, Wisconsin $3.69B AUM 30.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Hennessy Advisors Inc Novato, California $2.66B AUM 26.6% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.6B AUM 20.91% 1-Year Est. Return

Boston Partners's PAHC Position: Q3 2026 in Review

Boston Partners opened a new position in Phibro Animal Health (PAHC) in Q3 2026: 304,347 shares worth $10.9M. The stake represents 0.01% of the portfolio and ranks #456 among its holdings.

119 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

Boston Partners held 304,347 shares of Phibro Animal Health worth $10.9M as of Q3 2026.
Phibro Animal Health was a new Boston Partners position in Q3 2026.
Phibro Animal Health made up 0.01% of Boston Partners's portfolio in Q3 2026, its #456 holding.
119 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Boston Partners's 13F filing for Q3 2026, filed 10 Nov 2026.